Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.
Senapati J, Kantarjian HM, Haddad FG, Short NJ, Borthakur G, Kanagal-Shamanna R, Tang G, Jabbour E, DiNardo CD, Daver N, Montalban-Bravo G, Shah V, Alousi A, Shpall E, Popat U, Garcia-Manero G, Ravandi F, Kadia TM.
Senapati J, et al. Among authors: shah v.
Am J Hematol. 2024 Dec 24. doi: 10.1002/ajh.27561. Online ahead of print.
Am J Hematol. 2024.
PMID: 39718824